TM Publications 1991 - 1995

 

General

  1. J.A.J. Barbara and B.S. Combridge. 1991. Editorial. Transfusion Microbiology Newsletter, Vol 11, March 1991.
  2. 292(a). J.A.J. Barbara. 1993. Mutants on the march. Medical Laboratory World. April 1993, p9-10. (see 292(b)).
  3. 292(b). J.A.J Barbara. 1993. Snappy but misleading. Medical Laboratory World, June 1993, p5. (Correction to 292(a)).
  4. J.A.J. Barbara. 1993. The Hepatitis alphabet: Transfusion "Hot-Spots". Interface (Organon), Viral Hepatitis Workshop, Birmingham, 9 June 1993. (Abstract).
  5. J.A.J. Barbara. 1993. Biotechnology and diagnostic procedures. IV Regional Congress European Region, ISBT, Barcelona, 13-16 June 1993, p18-20. (Abstract).
  6. R.W. Carrell, K. Peters. J Cash et al (including M. Contreras and J.A.J. Barbara). 1993. Imprisonment of J.P. Allain. Lancet, Vol 342, July 24th 1993, p244.
  7. J.A.J. Barbara and F. Ala. (1994). The ethics of patenting: protecting the inventor while avoiding restrictive monopolisation. Transfusion Today, ISBT Newsletter, Number 20, 4-5.

Back to top

 

Transfusion Microbiology 

  1. J.A.J. Barbara, M. Contreras. The feasibility and value of long-term repositories of samples from blood donations. Transfusion Today, No. 8 December 1990, p. 3-4.
  2. M. Brennan, J.A.J. Barbara, M. Contreras. Screening for HTLV-1. Lancet vol 336: Dec 15, 1990, p. 1517.
  3. B.J. Cohen, A.M. Field, S. Gudnadottir, S. Beard and J.A.J. Barbara. Blood donor screening for parvovirus B19. Journal of Virological Methods, 30 (1990) 233-238.
  4. C.P. McDonald, S. Brown and J.A.J. Barbara. 1991. What tests are most suitable for CMV screening in transfusion centres? Med.Lab.Sci. 48, 90-92.
  5. K. Chippendale, J.A.J. Barbara, W. Elsenga et al. 1991. A new haemagglutination test for Treponema Pallidum: comparison with existing methods. Lab.Medica, March/April, p. 29-51.
  6. J.A.J. Barbara. 1991. Hepatitis C virus - implications for blood transfusion services. Insight, Infectious Disease Newsletter, No. 2., February 1991. p. 7-9.
  7. J.A.J. Barbara and M. Contreras. 1991. Non-A, non-B hepatitis and the anti-HCV assay. Vox Sanguinis 1991;60:1-7.
  8. B.S. Combridge and J.A.J. Barbara, 1991. BPL-RIA - The end of an era. Transfusion Microbiology Newsletter, Vol 11, March 1991.
  9. V. Rawlinson and J.A.J. Barbara. 1991. BBTS microbiology discussion group meeting, Manchester 3-4-90. Transfusion Microbiology Newsletter, Vol 11, March 1991.
  10. V. Rawlinson and J.A.J. Barbara. 1991. BBTS microbiology discussion group meeting, special meeting to discuss anti-HIV-1+2 assay cut-offs. NLBTC 15-5-90. Transfusion Microbiology Newsletter, Vol 11, March 1991.
  11. M. Contreras, J.A.J. Barbara and M. Brennan. 1991. Hepatitis C virus and transfusion Transmitted liver disease. J.Clin.Pathol. 1991;44:174.
  12. A.G. Bendle, D.R. Howell and J.A.J. Barbara. 1991. Pattern recognition in haemagglutination. Microplate Co-ordinating Group Meeting, The Royal London Hospital, 24 October 1990. Published April 1991, (BBTS).
  13. M. Contreras, J.A.J. Barbara, C.C. Anderson et al. 1991. Low incidence of non-A, non-B post-transfusion hepatitis in London confirmed by hepatitis C virus serology. The Lancet Vol 337:753.
  14. D. Howell, J.A.J. Barbara and M. Brennan. 1991. Hepatitis A virus, blood donors, and immunoglobulin preparations. The Lancet Vol 337:1165.
  15. J.A.J. Barbara. 1991. Blood transfusion - minimising the risks. Biological Sciences Review, Vol 3:No. 5:25-28.
  16. J.A.J. Barbara and P. Hewitt. 1991. Editorial. AIDS Newsletter, Vol 6:Issue 7:20 May 1991:p.1.
  17. B.S. Combridge and J.A.J. Barbara. 1991. RIA for HBsAg: A fading signal. Hepatitis Scientific Memoranda, No.2:1991 H2463 p.27-29.
  18. J.A.J. Barbara. 1991. Screening procedures for blood-borne viruses. Blood Separation and Plasma Fractionation, p 437-447. Edited by James Robinson Harris. Published by Wiley-Liss Inc. 1991.
  19. J.A.J. Barbara. 1991. Microbiology in the national blood transfusion service. Public Health Virology, 1989. Edited by Peter Morgan-Capner. Published by PHLS, (see also publication no. 171, CPHL bulletin).
  20. M. Contreras and J.A.J. Barbara. 1991. Creutzfeldt-Jakob disease and blood transfusion. British Medical Journal, Vol 302, 11 May 1991, p. 1148.
  21. M. Contreras, J.A.J. Barbara and P. Hewitt, 1991. Creutzfeldt-Jakob disease and blood transfusion. British Medical Journal, Vol 303, 20 July 1991, p.187.
  22. J.A.J. Barbara, (against), J.L. Brown and H.C. Thomas, (for). 1991. Forum: Blood transfusion services should have begun screening for Hepatitis C when an antibody assay first became available. Reviews in Medical Virology, Vol 1:p.67-71.
  23. N.J. Berry, R. Salker, M. Contreras, J.A.J. Barbara and R.S. Tedder. 1991. A comparison of four enzyme immunoassays for the simultaneous detection of HIV-1- and HIV-2-specific antibody. Journal of Virological Methods, 34:91-100.
  24. J.A.J. Barbara and M. Contreras. 1991. Hepatitis C virus screening: UK blood transfusion service on the threshold. Med.Lab.Sci. 48:171-174.
  25. S Aloysius, D.R. Howell and J.A.J. Barbara. 1991. Antibody to hepatitis C virus in blood donors found positive for other agents. I. Treponemal infection. Transfusion Medicine, 1:191-193.
  26. M.C. Moore, J.A.J. Barbara and P.E. Hewitt. 1991. Antibody to hepatitis C virus in blood donors found positive for other agents. II. Ant-HIV-1. Transfusion Medicine, 1:195-197.
  27. J.A.J. Barbara. 1991. Screening for hepatitis C. Vector, Issue 5.J.A.J. Barbara, D.R. Howell, M. Contreras and P.E. Hewitt. 1991. Testing antenatal patients for HBsAg at a regional blood transfusion centre. Transfusion Medicine. Edited by AH Waters, published by Blackwell Scientific Publications, Vol 1, Supplement 2, September 1991. p.76. (Abstract).
  28. M. Contreras. 1991. HIV transmission by blood transfusion. Proceeding of the Australian Society of Blood Transfusion and Twenty-Ninth Meeting of the Haematology Society of Australia. Melbourne, Australia, 25-28 September 1991. (Abstract).
  29. M. Brennan, M. Rodriguez and J.A.J. Barbara. 1991. Mandatory Microbiological Screening tests for blood donations in the U.K. ISBT 3rd Regional Congress, European Region. Abstracts Vol , p.19. 13-16 October 1991. (Abstract).
  30. J.A.J. Barbara. 1991. Parallel Assessment of Anti-HCV assays in the U.K. ISBT 3rd Regional Congress, European Region. Abstracts Vol 1, p.25. 13-16 October 1991. (Abstract).
  31. J.A.J. Barbara. 1991. The Transfusion Microbiology Discussion Group of the British blood transfusion society. ISBT 3rd Regional Congress, European Region. Abstracts Vol 1, p.164, 13-16 October 1991, (Abstract).
  32. J.A.J. Barbara. 1991. Introduction Enhanced Luminescence: Applications for hepatitis testing. Edited by J.A.J. Barbara. Published by the Medicine Group (UK) Ltd. 1991.
  33. D.R. Howell. 1991. An evaluation of the Amerlite HBsAg assay in a U.K. blood bank. Enhanced Luminescence: Application for hepatitis testing. Edited by J.A.J. Barbara. Published by the Medicine Group (UK) Ltd. 1991.
  34. M.A. Rodriguez, J. Runganga, M. Contreras et al. 1991. Is there a wastage or resources due to non-specificity of anti-HIV ELISAs? Transfusion Medicine. 1991, 1, 269-271.
  35. M.A. Rodriguez, J. Runganga, M. Contreras et al. 1991. Anti-HIV-1: extended validation of a modified gelatin particle agglutination assay, and its use with an image analyser. Medical Laboratory Sciences. 1991, 48, 256 260.
  36. J.A.J. Barbara. 1991. Screening blood donors for retroviruses. The Journal of Biomedical Sciences. Vol 2, No. 2, October 1991.
  37. P.E. Hewitt, J.A.J. Barbara, M. Contreras. 1991. Hepatitis C virus. British Medical Journal 23rd Nov 1991, Vol 303: 1330-1331.
  38. D.R. Howell, J.A.J. Barbara. P.E. Hewitt. 1991. Diagnosis of acute hepatitis B by qualitative assay of specific IgM antibody. Journal of Clinical Pathology, Dec. 1991. Vol 44, No 12: 1038-1039.
  39. J.A.J. Barbara, M. Contreras. 1991. Post-transfusion NANBH in the light of a test for anti-HCV. Blood Reviews, Dec 1991, Vol 5, No 4: 234-239.
  40. S. MacLennan, J.A.J. Barbara, P.E. Hewitt et al. 1992. Screening blood donations for HCV. Lancet, Jan 11th 1992, Vol 339: 131-132.
  41. C. Mattock, B. Brace. 1992. New hepatitis virus. Journal of the Royal Society of Medicine. Jan 1992, Vol 85: 50-53.
  42. M. Contreras, J.A.J. Barbara. 1992. Screening for HIV P24 antigen. Lancet, Feb 1992, Vol 339: 438-439.
  43. A. Puckett, G. Davison, C.C. Entwistle, J.A.J. Barbara. 1992. Post transfusion septicaemia 1980-1989: Importance of donor arm cleansing. Journal of Clinical Pathology, 1992; 45: 155-157.
  44. J.A.J. Barbara. 1992. Hepatitis C virus. Implications for blood transfusion. Blood Focus Newsletter, April 1992, No 2: 3-7.
  45. J.A.J. Barbara. 1992. Transfusion-associated hepatitis. Advances in Haematology 24th Annual Course, June 15-19 1992: 88.
  46. J.A.J. Barbara. 1992. Plasma and derivatives: Inactivation of viruses. European School of Haematology. Paris, June 1992.
  47. J.A.J. Barbara. 1992. Safety of blood transfusion: Viral transmission. European School of Haematology, Paris, June 1992.
  48. C.P. McDonald, J.A.J. Barbara, A. Al-izzi et al. 1992. Anti HBs detection: A modified passive haemagglutination assay. Medical Laboratory Sciences, 1992 49: 66-69.
  49. J.A.J. Barbara. 1992. Hepatitis C and blood transfusion. Current Opinion in Infectious Diseases 1992, 5: 536-541.
  50. M.J. Brennan, J. Runganga, J.A.J. Barbara et al. 1992. The prevalence of anti-HTLV in North London blood donors. HTLV Symposium. Montpellier 26-27th march 1992. Abstract.
  51. J.A.J. Barbara. 1992. Experiences with routine HCV screening in the U.K. Interface: New challenges in the Blood Bank Screening Environment. Paris 26-27th October 1992. Abstract.
  52. D.R. Howell, S.D. Brown and J.A.J. Barbara. 1992. Hepanostika HBsAg in a busy blood transfusion centre. Interface: New Challenges in the Blood Bank Screening Environment. Paris 26-27th October 1992. Abstract.
  53. A.G. Bendle, I.H. Rayfield. 1992. A photodensitometric method for calibrating and monitoring liquid handling devices. Transfusion Medicine. Vol 2. Supplement 1, Sept. 1992. p43. Abstract.
  54. D.R. Howell, C.J. Thompson and J.A.J. Barbara. 1992. Anti-HAV in blood donors in relation to HNIg. Transfusion Medicine. Vol 2, Supplement 1, Sept 1992. p97. Abstract.
  55. D.R. Howell, S.D. Brown and J.A.J. Barbara. 1992. The possible advantages of using on-line computer packages for the analysis of immunoassays. Transfusion Medicine. Vol 2, Supplement 1, Sept. 1992. p97. Abstract.
  56. J.A.J. Barbara, G. Haase and M. Brennan. 1992. The HCV 'Indeterminate' donor. The twilight zone. Transfusion Medicine. Vol 2. Supplement 1, Sept 1992, p94. Abstract.
  57. J. Runganga, M. Brennan, J.A.J. Barbara. 1992. Optimising the modified anti-HTLV GPA screening dilution. Transfusion Medicine. Vol 2, Supplement 1, Sept 1992, p102. Abstract.
  58. S. Aloysius, J.A.J. Barbara, M.J. Beard et al. 1992. ALT levels and anti-HBc in donors reactive for anti-HCV. Transfusion Medicine. Vol 2, Supplement 1, Sept 1992, p91. Abstract.
  59. C.P. McDonald, J.A.J. Barbara, D.R. Howell et al. 1992. Procurement of anti-HBs immune plasma. Transfusion Medicine. Vol 2, Supplement 1, Sept 1992. p100. Abstract.
  60. M. Brennan, P.E. Hewitt, C Moore et al. 1992. Confidential unit exclusion: the North London Blood Transfusion Centre's experience. Transfusion Medicine, Vol 2, Supplement 1, Sept 1992, p20. Abstract.
  61. M. Brennan, P.E. Hewitt, C. Moore et al. 1992. Hepatitis B core antibody in self-identified 'high-risk' donors. Transfusion Medicine. Vol 2, Supplement 1, Sept 1992, p20. Abstract.
  62. J.A.J. Barbara 1992. Hepatitis C virus and blood transfusion. 20th Triennial Conference. Institute of Medical Laboratory Sciences. 5-12 Sept 1992, Liverpool, p66. Abstract.
  63. J.A.J. Barbara and M. Contreras. 1992. Infectious complications of blood transfusion: Bacteria and Parasites. ABC of Transfusion. edited by M. Contreras. Published by BMJ, 1992 p45-48. (Revised version see publications 169 and 186).
  64. J.A.J. Barbara, M. Contreras. 1992. Infectious complications of blood transfusion: Viruses. ABC of Transfusion. edited by M. Contreras. Published by BMJ, 1992 p49-52. (Revised version see publications 170 and 187).
  65. D.R. Howell, J.A.J. Barbara and M.J. Seghatchian. 1992. Microbiological safety considerations in the blood transfusion service. International Symposium ICCS "The Future Practice of Contamination Control". 21-25 Sept '92 London, p317-319. Abstract.
  66. C. McDonald, M. Vickers, A. Al-izzi et al. 1992. Long term monitoring of key areas of processing and control using settle plates and a centrifugal air sampler. International Symposium ICCS "The Future Practice of Contamination Control". 21-25 Sept '92 London, p315-316. Abstract.
  67. J.A.J. Barbara, S. Aloysius, C Perrons. 1992. Improved sensitivity of Ortho second generation anti-HCV elisa. Revista Paulista de Medicina. Sao Paulo Medical Journal, Special Abstract Supplement, XXII Congress of the International Society of Blood Transfusion. Brazil '92 Vol. 110(5) 1992. Abstract.
  68. J.A.J. Barbara. 1992. Hepatitis B variants: their importance in blood transfusion. Boletim. Educational Programme Summary of Conference, XXII Congress of the International Society of Blood Transfusion, Brazil '92. Vol XIV, No 160, 1992, p148-149.
  69. J.A.J. Barbara. 1992. Automation in Transfusion Microbiology. Boletim. Educational Programme Summary of Conference, XXII Congress of the International Society of Blood Transfusion, Brazil '92. Vol XIV, No 160, 1992, p187-189.
  70. J.A.J. Barbara. 1992. Combined testing for viral markers. Virological Safety Aspects of Plasma Derivatives. Cannes, Nov 3-6 1992 p37. Abstract.
  71. J.A.J. Barbara. 1992. Hepatitis C and what is means to be positive: diagnosis and epidemiology. Maternal and Child Health, Vol 17, No 11, Nov 1992, p332-335.
  72. N.A.B. Anderson, A. Raafat, K.H. Shwe, J.A.J. Barbara et al. U.K. multicentre study of blood donors for surrogate markers of non-A non-B hepatitis. Part 1: Alanine transferese and anti-HBc testing. Transfusion Medicine, Vol 2, No 4. Dec 1992, p301-310.
  73. M. Contreras. 1992. Viral infections transmitted by blood transfusion. 20th World Congress of Medical Technology. Dublin, Ireland 26-31 July 1992. Abstract.
  74. J.A.J. Barbara. 1992. Teaching and education in transfusion medicine. ISBT Regional Congress. Prague 15th Oct, 1991, p83. Abstract.
  75. J.A. Glazebrook. B.C. Rodgers, J. Corbishley, J.A. Garson, D. Parker, J.A.J. Barbara et al. 1992. Diagnostic reagents for hepatitis C virus. Archives of Virology, Supplement 4: 219-221
  76. J.A.J. Barbara. 1992. Screening blood donors for retroviruses. Proceedings of the Symposium Infectious Complications of Blood Transfusion. Canada 23rd Sept, 1992. p4-9. (The Royal College of Physicians and Surgeons of Canada).
  77. J.A.J. Barbara. 1992. Experiences with routine HCV screening in the UK. Interface Proceedings - New Challenges in the Blood Bank Screening Environment. Paris, October 1992, p13-14.
  78. M. Contreras, J.A.J. Barbara. 1993. Hepatitis C and blood transfusion services. Hepatitis Update, The Royal Free Hospital School of Medicine, February 1993, p15. (Abstract).
  79. P.E. Hewitt, J.A.J. Barbara. 1993. Significance of P24 on Immunoblot with a negative anti-HIV ELISA results. Vox Sanguinis 1993: 64: 63-64.
  80. M.J. Brennan, J.A.J. Barbara. 1993. Transfusion-transmitted disease. Current Opinion in Hematology 1993:1:320-329.
  81. J.A.J. Barbara, J.A. Garson. 1993. Polymerase Chain Reaction and transfusion microbiology. Vox Sanguinis 1993:64:73-81.
  82. J.A.J. Barbara. 1993. Challenges in transfusion microbiology. Transfusion Medicine Reviews, Vol VII, No. 2 (April) 1993: pp96-103.
  83. J.A.J. Barbara. 1993. HCV Update of screening data in blood and plasma donation. IV Regional Congress European Region, ISBT, Barcelona, 13-16 June 1993, p170-172. (Abstract).
  84. C. Moore, J.A.J. Barbara, P.E. Hewitt. 1993. Protection against Hepatitis A. Transfusion Medicine, Vol. 3, No. 2, June 1993, p164.
  85. 297(a). M. Brennan, J.A.J. Barbara, M. Contreras. 1993. Testing blood donors for HTLV-II. Lancet, vol 342, July 10th 1993, p126. (see 297(b)).
  86. 297(b). M. Brennan, J.A.J. Barbara, M. Contreras. 1993. Testing blood donors for HTLV-II. Lancet vol 342, Aug 28th 1993, p564. (Correction to 297(a)).
  87. 299(a). J.A.J. Barbara. 1993. Transfusion-transmitted infections and their impact on virology. Current Medical Literature, Virology, Vol. 2, Number 3, August 1993, p67-72. (see 299(b)).
  88. 299(b). J.A.J. Barbara. 1993. Erratum - Transfusion-transmitted infections and their impact on virology. Current Medical Literature, Virology, Volume 2, Number 4, November 1993, p107. (Correction to 299(a)).
  89. J.A.J. Barbara. 1993. Requirements for standards in transfusion microbiology. British Blood Transfusion Society Newsletter, No. 30, August 1993, p5-7.
  90. D.R. Howell, S.D. Brown, J.A.J. Barbara. 1993. The derivation of cut-offs in HBsAg immunoassays. Seventh International Congress on Rapid Methods and Automation in Microbiology and Immunology. London, 12-15 September 1993, p77. (Abstract p10/9).
  91. J.A.J. Barbara. 1993. Microbial trends in the Blood Transfusion Service. Microbe '93. Sheffield, 16-19 September 1993, p17-18. (Abstract).
  92. J.A.J. Barbara. 1993. Transfusion Microbiology: The Developing technology. Transfusion Medicine, Vol 3, Supplement 1, September 1993, p70. (abstract SS14).
  93. K. Ryan, S. MacLennan, C. Moore et al. 1993. Follow-up of anti-HCV positive blood donors. Transfusion Medicine, Vol 3, Supplement 1, September 1993, p112. (Abstract P64).
  94. S. MacLennan, C. Moore, J.A.J. Barbara et al. 1993. Risk factors in HCV-infected blood donors. Transfusion Medicine, Vol 3, Supplement 1, September 1993, p112. (Abstract P65).
  95. S. Aloysius, J.A.J. Barbara. 1993. Seroconversion for Hepatitis C Virus in blood donors. Transfusion Medicine, Vol 33, Supplement 1, September 1993, p112. (Abstract P67).
  96. D.R. Howell, S.D. Brown J.A.J. Barbara. 1993. An HBsAg assay that could combine acceptable sensitivity and specificity. Transfusion Medicine, Vol 3, Supplement 1, September 1993, p113. (Abstract P70).
  97. S.D. Brown, J.A.J. Barbara. 1993. Spontaneous loss of HBeAg and the development of anti-HBe in long-term follow-up of blood donors found to be HBsAg-positive. Transfusion Medicine, Vol 3, Supplement 1, September 1993, p113. (Abstract P71).
  98. C.P. McDonald, A. Housego, J.A.J. Barbara. 1993. Quality assurance of the serum volumes delivered into microplates by a robotic sampler. Transfusion Medicine, Vol 3, Supplement 1, September 1993, p114. (Abstract P75). Winner of best poster prize at BBTS Lancaster 1993.
  99. J.A.J. Barbara. 1993. Internal quality control from the Transfusion Microbiologist's viewpoint. Internal Quality Control for Serodiagnosis: Principles and Practice. CPHL, October 12th 1993. (Abstract).
  100. M. Brennan, J. Runganga, J.A.J. Barbara et al. 1993. Prevalence of antibodies to human T cell leukaemia/lymphoma virus in blood donors in North London. British Medical Journal, 13th November, Vol 307, p1235-1239.
  101. J.A.J. Barbara. 1993. Questions of quality: How much HBsAg is there in this sample and is our assay sensitive enough to detect it? Vox Sanguinis 1993;65:249-250.
  102. M. Contreras. 1993. German blood scandal. British Medical Journal, Vol 307, 27 November 1993, p1420.
  103. D.R. Howell, C.J. Thompson, J.A.J. Barbara. 1993. Anti-HAV prevalence in a U.K. urban blood donor population and the effect on human normal Ig provision. Transfusion Medicine, 1993, 3, 285-289.
  104. P.E. Hewitt. 1993. In: International Forum: How far shall we go in the predonation selection of blood donors to safeguard patients for blood-transfusion-related infections? PP.6-8. Editor H.W. Reesink. Vox Sanguinis 1993;65:1-9.
  105. J.A.J. Barbara. 1993. Combined testing for viral markers. Virological safety Aspects of Plasma Derivatives. Edited by F. Brown. Published by Karger, 1993, vol 81, p81-83.
  106. M. Brennan, J.A.J. Barbara, M. Contreras. 1993. HTLV in United Kingdom blood donors. The Bulletin of the Royal College of Pathologists. Number 84, September 1993, p23-24.
  107. J.A.J. Barbara. 1993. Bulk testing for infectious disease. Analytical Proceedings, (of the Royal Society of Chemistry), Dec 1993, Vol 30, p487-488.
  108. J.A.J. Barbara. 1994. The Hepatitis Alphabet: Transfusion "hot-spots". Interface Proceedings of the Viral Hepatitis Workshop, 9 June 93, Birmingham, p8-11.
  109. A. Kitchen and J.A.J. Barbara. 1994. Transfusion Microbiology Discussion Group: Lancaster 21-24 September 1993. Summary of Proceedings. BBTS Newsletter No. 31, January 1994, p5-8.
  110. J.A.J. Barbara, D. Samuel and A. Slopecki. 1994. Les echantillons temoins internes nationaux sont essentiels. La Gazette de la Transfusion, No. 94, January 94, p12-13.
  111. J.A.J. Barbara. 1994. HTLV-1 in multiply transfused patients in Trinidad and Tobago. Vox Sanguinis, 66, 152.
  112. K.E. Ryan, S. MacLennan, J.A.J. Barbara, P.E. Hewitt. 1994. Follow up of blood donors positive for antibodies to hepatitis C virus. Brit Med J, 308, 696-697.
  113. J.A.J. Barbara. 1994. Any Questions: "How soon after being treated for Lyme disease can donors give blood?" British Medical Journal, 308, 711.
  114. P.E. Hewitt. 1994. HIV testing and blood recipients (Letter). Lancet, 343, 797-798.
  115. J.A.J. Barbara. 1994. Transfusion-transmitted infections and their impact on virology. Chapter 4, Infectious Diseases. Editors: A. Bentley, R. Davidson, R. Heyderman and M. Zuckerman. Publishers: Current Medical Literature Ltd, 94-101 (Compendium), see also previous publication, no. 299a.
  116. J.A.J. Barbara. 1994. Viral hazards of transfusion. Journal of Medical Microbiology, 40, 227-228.
  117. S. MacLennan, M.C. Moore, P.E. Hewitt, S. Nicholas, and J.A.J. Barbara. 1994. A study of anti-hepatitis C positive blood donors: the first year of screening. Transfusion Medicine, 4, 125-133.
  118. J.A.J. Barbara. 1994. Potential transmission of infection by transfusion of blood and blood products. Colloquium 3: Blood-Borne Infection. 63rd Annual Meeting and Summer Conference, Heriot-Watt, University, Edinburgh, 13-15 July 1994, 9-10.
  119. J.A.J. Barbara. 1994. Hepatitis B: Old virus, new problems? Vox Sanguinis, 67, (suppl 3), 239-242.
  120. I.M. Williamson, I. Reeves, J. Petrik, M. Contreras, S. Aloysius, J. Barbara, J. Harrison, A. Kitchen, J-P. Allain. 1994. Does dual positivity in two anti-HCV ELISAs define true anti-HCV reactivity? Vox Sanguinis, 67.S2.94; 100 (Abstract 0472).
  121. J.A.J. Barbara. 1994. The side effects of blood transfusion: transmissible infections. Chapter 13. Transfusion Medicine: A European Course on Blood Transfusion. Co-ordinators: William Van Aken and Bernard Genetet. Published by Centre National d´Enseignement á Distance, 273-311.
  122. J.A. Garson and J.A.J. Barbara. 1994. Polymerase chain reaction and transfusion-related infections. Chapter 40, Scientific Basis of Transfusion Medicine: Implications for Clinical Practice. Editors: Anderson, K.C. and Ness, P.M. Published by W.B. Saunders, Philadelphia, 726-736.
  123. A. Kitchen and J.A.J. Barbara. 1994. Transfusion-transmitted non-viral infections. Current Opinions in Infectious Diseases, 7, 493-498.
  124. J.A.J. Barbara. 1994. Internal quality control from the transfusion microbiologist´s viewpoint. Internal Quality Control for Serodiagnosis: Principles and Practice. CPHL Seminar, Editor: Judith Hawkins, p7.
  125. D. Bennett, M.F. David, J. Gillon, D. Howell, et al. 1994. A European multicentre evaluation of the Murex enzyme immunoassay for detection of Hepatitis B surface antigen (HBsAg). Monograph IX: Murex HBsAg. Published by Ellis and Sons, Dartford, 1-6.
  126. J.A.J. Barbara. 1994. Selecting donors for high titre antibodies. Transfusion Medicine, 4, Suppl 1, 21 (Abstract SS40).
  127. P.E. Hewitt. 1994. Investigation of post-transfusion HIV infection. Transfusion Medicine, 4, suppl 1, 24 (Abstract F5).
  128. J.A.J. Barbara and D.R. Howell. 1994. Error rate for manual microbiological testing. Transfusion Medicine, 4, suppl 1, 24, (Abstract F6).
  129. G.S. Godfrey, M.C. Moore, J.A.J. Barbara and P.E. Hewitt. 1994. Does HBV infection reflect a ´high-risk´ lifestyle? Transfusion Medicine, 4, Suppl 1, 26 (Abstract F13).
  130. M.C. Moore, P.E. Hewitt, R.S. Tedder and J.A.J. Barbara. 1994. Lessons learned from a case of acute HBV in a blood donor. Transfusion Medicine, 4, Suppl 1, 52 (Abstract 98).
  131. M.A. Zuckerman, A.E. Hawkins, J.A.J. Barbara et al. 1994. The identification of an Hepatitis B transmission event by nucleotide sequence analysis. Transfusion Medicine, 4, suppl 1, 52 (Abstract 99).
  132. M.H. Bailey, D.R. Howell, and J.A.J. Barbara. 1994. Evaluation of end-point sensitivity and performance of anti-HBc assays. Transfusion Medicine, 4, suppl 1, 53 (Abstract P102).
  133. D.R. Howell, S.D. Brown and J.A.J. Barbara. 1994. Anti-HBc screening of blood donors. Transfusion Medicine, 4, suppl 1, 53 (Abstract P103).
  134. D.R. Howell and J.A.J. Barbara. 1994. The projected benefit at NLBTC of a donor readmission protocol based on the use of alternative assays with equivalent sensitivity. Transfusion Medicine, 4, suppl 1, 53 (Abstract P104).
  135. R. Ahya, R. Salker, and J.A.J. Barbara. 1994. Gelatin particle agglutination assay for anti-HIV 2 antibodies: a rapid and economical modification, without loss of sensitivity. Transfusion Medicine, 4, Suppl 1, 54 (Abstract P105).
  136. J.A.J. Barbara, S. Aloysius and P.E. Hewitt. 1994. Enhanced intravenous drug use exclusion on donor questionnaire does not reduce anti-HCV positive rates in new donors. Transfusion Medicine, 4, suppl 1, 54 (Abstract P107).
  137. D.R. Howell, J.A.J. Barbara and A.G. Bendle. 1994. Routine Q.C. in transfusion microbiology I: The value of linked spreadsheets. Transfusion Medicine, 4, suppl 1, 55 (Abstract P110).
  138. D.R. Howell, J.A.J. Barbara and J. Stivala. 1994. Routine Q.C. in transfusion microbiology II: Statistical quality control and the HBsAg working standard. Transfusion Medicine, 4, suppl 1, 55 (Abstract P111).
  139. D.R. Howell and J.A.J. Barbara. 1994. Routine Q.C. in transfusion microbiology III: The importance of the effective investigation of reported post-transfusion hepatitis. Transfusion Medicine, 4, suppl 1, 55 (Abstract P112).
  140. I.H. Rayfield, A.G. Bendle and J.A.J. Barbara. 1994. Establishment and Management of a Low cost archive for the long term storage of donor serum samples. Transfusion Medicine, 4, Suppl 1, 56 (Abstract P113).
  141. P.E. Hewitt, J.A.J. Barbara and M. Contreras. 1994. Donor Selection and Microbial Screening. Vox Sanguinis, 67, (suppl 5), 14-19.
  142. J.A.J. Barbara. 1994. The price of blood tests. The Independent, Tuesday 20 December 1994, p13.
  143. M.H. Bailey, D.R. Howell and J.A.J. Barbara. 1994. Anti-HBc assays: evaluation of end-point sensitivity and performance. British Journal of Biomedical Science, 51, 341-344.
  144. Howell, D.R., Barbara, J.A.J. and Brown, S.D. (1994). The use of the international standard in HBsAg enzyme immunoassays. The Ligand Quarterly, 13, 1, 100, (Abstract).
  145. Barbara, J.A.J. (1994). Questions and answers. SETS, 17, 11.
  146. Barbara, J.A.J. and Ferguson, M. (1995). Use of external controls in transmissible-disease testing. Transfusion, 35, 3, 278-279, (Letter).
  147. Brennan, M.T., Hewitt, P.E., Moore, C., Hall, G. and Barbara, J.A.J. (1995). Confidential unit exclusion: the North London Blood Transfusion Centre´s experience. Transfusion Medicine, 5, 51-56.
  148. Cummins, D., Halil, O., Amin, S., Chiodini, P., Hewitt, P.E. and Radley-Smith, R. (1995). Visceral Leishmaniasis (kala-azar) after blood transfusion. British Society for Haematology, Brighton, 3-6 April ´95, British Journal of Haematology, 14, (Abstract 46).
  149. Cummins, D., Amin, S., Halil, O., Chiodini, P., Hewitt, P.E. and Radley-Smith, R. (1995). Visceral Leishmaniasis after cardiac surgery. Archives of Disease in Childhood, 72, 235-236.
  150. Barbara, J.A.J. (1995). Prevention of disease transmission through tissue grafts. British Association of Tissue Banks, University of York, 10-11 April ´95, 6, (Abstract).
  151. Kitchen, A.W. and Barbara, J.A.J. (1995). Prevention of transfusion-transmitted infection. Current Therapy in Haematology - Oncology. Edited by MC Brain and PP Carbone. Published by Mosby, Missouri, 213-217, (Chapter).
  152. Barbara, J.A.J. (1995). Hepatitis C and what it means to be positive: diagnosis and epidemiology. Postgraduate Doctor, Middle East, June 1995, 18, 6, 232-238.
  153. Contreras, M. (1995). HBV PCR. Proceedings of new applications of emerging molecular diagnostics for infectious diseases. Cambridge Healthtech Institute. June 1995, London, England.
  154. Brown, S.D., Barbara, J.A.J., Lambert, J. et al. (1995). Spontaneous loss of HBeAg and development of anti-HBe during long-term follow-up of blood donors found to be HBsAg positive. British Journal of Biomedical Science, 52,106-109.
  155. Barbara, J.A.J., Hewitt, P.E., Howell, D.R., Moore, M.C., Aloysius, S.K. and Tedder, R.S. (1995). Prospective Study of Post-Transfusion Hepatitis in North London: Improved Sensitivity of Enhanced Assays (Letter to the Editor). Vox Sang, 69, 72.
  156. Regan, F.A.M., Barbara, J.A.J., Bailey, M., Hewitt, P., Contreras, M., Callaghan, T. (1995). Study to determine the incidence of transfusion transmitted infection in recipients of blood transfusion : interim results. 5th Regional Congress of ISBT, Venice, Italy, 187, (Abstract POS 212).
  157. Barbara, J.A.J. (1995). Surrogate testing in blood transfusion: some introductory thoughts. International Society of Blood Transfusion V Regional Congress, Italy, 2-5 July ´95, 57 (Abstract PAR45).
  158. Barbara, J.A.J. (1995). BBTS Microbiology discussion group meeting. NIBSC - introduction of anti-HCV, and update on anti-HIV national standards. BBTS Newsletter Special Report, 3, Aug 95, 8.
  159. Brennan, M., de Silva, P.M. and Barbara, J.A.J. (1995). Safety of blood components. Modern Transfusion Medicine. Edited by Derwood H Pamphilon. Published by CRC Press.
  160. Barbara, J.A.J. (1995). Why investigate post-transfusion hepatitis? Transfusion Medicine, 5, Suppl 1, 10 (Abstract S17).
  161. Anderson, N.A.B., Kirkwood, J., Caul, E.O., Barbara, J.A.J. et al. (1995). Possible transmission of hepatitis B by two HBsAg negative, anti-HBc positive blood donors. Transfusion Medicine, 5, suppl 1, 47 (Abstract P88).
  162. Howell, D.R., Hewitt, P.E. and Barbara, J.A.J. (1995). The investigation of post-transfusion hepatitis. Transfusion Medicine, 5, suppl 1, 47, (Abstract P90).
  163. Soldan, K., Barbara, J.A.J., Heptonstall, J. (1995). Transfusion safety: is an agent transmissible and, if so, how often? Transfusion Medicine, 5, suppl 1, 47 (Abstract P91).
  164. Hughes, W., Barr, A., Dow, B.C., Follett, E.A.C. and Barbara, J.A.J. (1995). A multicentre assessment of the specificity of anti-HBc screening tests from 10 manufacturers. Transfusion Medicine, 5, suppl 1, 48 (Abstract P92).
  165. Rosmarin, M.N., Howell, D.R. and Barbara, J.A.J. (1995). Comparative assessment of TPHA and treponema pallidum particle agglutination for detection of antibodies to T. Pallidum. Transfusion Medicine, 5, suppl 1, 50, (Abstract P102).
  166. Rayfield, I.H. and Barbara. J.A.J. (1995). The benefits of careful monitoring of sharps injuries. BBTS Scotblood Conference, Stirling, September 1995, 75, (Abstract SP02).
  167. McDonald, C.P., Rayfield, I.H., Cook, R. et al. (1995). Anti-CMV robotic selective sampling and total assay automation. BBTS Scotblood Conference, Stirling, September 1995, 77, (Abstract SP09).
  168. Howell, D.R., Welfare, V. and Barbara, J.A.J. (1995). Investigation of the effect of panavirucide, an anti-microbial agent, on the sensitivity of various commercial assays. BBTS Scotblood Conference, Stirling, September 1995, 77, (Abstract SP11).
  169. Hughes, W., Barr, A., Dow, B.C., Follett, E.A.C. and Barbara, J.A.J. (1995). A multicentre assessment of the specificity of ten anti-HBc screening tests. Transfusion Medicine, 5, 225-230.
  170. Kitchen, A., Rayfield, I.H. and Barbara, J.A.J. (1995). Automation of mandatory testing of blood donations. Transfusion Science, 16, 3, 213-218.

Back to top

 

Bacteriology

  1. C.P. McDonald, J.A.J. Barbara, A. Al-Izzi et al. 1991. Modified latex agglutination test for anti-toxoplasma gondii screening. Transfusion Medicine. Edited by AH Waters, published by Blackwell Scientific Publications, Vol 1, Supplement 2, September 1991, p.79. (Abstract).
  2. J.A.J. Barbara, P. Hewitt. S Enright. 1993. Routine blood donor screening for syphilis can reveal recent infection. Vox Sanguinis 1993;65:243.
  3. C.P. McDonald, C. Heatley, S. Hartley et al. 1994. The validation and monitoring or pre-venepuncture arm cleansing at the NLBTC. Transfusion Medicine, 4, suppl 1, 56 (Abstract P114).
  4. Barbara, J.A.J. (1995). BBTS Microbiology discussion group meeting. Transfusion Bacteriology. BBTS Newsletter Special Report, 3, Aug 95, 3.

Back to top

 

Surveillance and Epidemiology

 

  1. J.A.J. Barbara. 1991. Prevention and prevalence. Medical Laboratory World, June 1991, p.9-10
  2. M.J. Brennan, J. Runganga, M. Contreras, M. Rodriguez, A. Banya, J.A.J. Barbara. 1991. Interim report of the assessment of the prevalence of anti-HTLV in 100,000 North London blood donors. Transfusion Medicine. Edited by AH Waters published by Blackwell Scientific Publications, Vol 1, Supplement 2, September 1991, p.29. (Abstract).
  3. D.R. Howell, J.A.J. Barbara, M. C. Contreras and P.E. Hewitt. 1991. HBsAg in UK blood donors since 1974 - The value of central collation. Transfusion Medicine Edited by AH Waters, published by Blackwell Scientific Publications, Vol 1, Supplement 2, September 1991. p.75. (Abstract).J.A.J. Barbara. 1992: in: International Forum: Blood donor screening or 'Over-Screening': How far to go in avoiding transmission of infectious agents? PP 62-63. Editors: H.W. Reesink and U.E. Nydegger. Vox Sang. 63-1 92, p59-69.D.R. Howell, J.A.J. Barbara. 1992. How often is Icterus associated with the HBV carrier state? Journal of Hepatology. Supplement 1 Vol 17. 1992. S24 p9. Abstract.
  4. S. Wendel, J.A.J. Barbara, M.J. Peppe, et al. 1992. The prevalence of HTLVI/II antibodies from Sao Paulo blood donors with comparison of reactive samples by different methods. Revista Paulista de Medicina. Sao Paulo Medical Journal. Special Abstract Supplement XXII Congress of the International Society of Blood Transfusion Brazil '92. Vol 110(5) 1992. Abstract.
  5. J.A.J. Barbara. 1992. Transfusion-transmitted infections: epidemiology relevant to blood safety. Chapter 18. Quality Assurance in Transfusion Medicine. Vol 1. Conceptual, Serological and Microbiological Aspects. Editors: G Rock and M J Seghatchian. Published by CRC Press Nov 1992. Vol 1, p419-444.
  6. D.R. Howell, J.A.J. Barbara. 1993. UK Register of HBsAg positive donors: Update. Transfusion medicine, Vol 3, Supplement 1, September 1993, p114. (Abstract P73).
  7. A. Kitchen, J.A.J. Barbara. 1993. Epidemiology and prevention. Published in Viral Hepatitis Scientific Basis and Clinical Management. Edited by A.J. Zuckerman and H.C. Thomas. Published by Churchill Livingstone, Edinburgh, p18.
  8. T.A. Callaghan, M.T. Brennan, J.A.J. Barbara, M. Bailey, G. Century, D.R. Howell and M.C. Contreras. 1994. Incidence of Transfusion-Transmitted Infection. Vox Sanguinis, 67.S2.94; 23 (Abstract 0121).
  9. P.E. Hewitt. (1994). Risk estimates for transfusion-transmitted infection. Clin Lab Haemat, 16, 394-395.
  10. Soldan, K., Barbara, J.A.J., Ramsay, M. et al. (1995). What can blood donor testing contribute to hepatitis C virus surveillance in England? PHLS 20th Annual Scientific Conference, Warwick, September 1995.
  11. Hewitt, P.E. (1995). Concern about "lookback" exercise for hepatitis C. Brit Med J, 311, (28 Oct 95), p1169 (Letter).
  12. Barbara, J.A.J. (1995). in : International Forum: Do surrogate tests improve the safety of the blood supply? 285-286. Eds. RY Dodd, HW Reesink. Vox Sang, 69, 280-291.

 

Back to top

Also see